Pilot Study of How Sex Differences in Early Life U

The National Institutes of Health within the Department of Health and Human Services is soliciting research and development services for a pilot study examining how sex differences in early life contribute to the developmental origins of disease. This procurement falls under the Research and Development in the Physical, Engineering, and Life Sciences category and specifically focuses on health research and development services and applied research. The solicitation seeks qualified contractors to conduct scientific research that will investigate the relationship between early life sex differences and their long-term health implications in disease development. The opportunity was posted on September 22, 2025, with a tight response deadline of September 25, 2025, providing potential contractors only three days to prepare and submit their proposals. The evaluation criteria and specific contract requirements are not detailed in the available information, though the research nature suggests contractors will need demonstrated expertise in developmental biology, sex difference research, and disease origins studies.

This procurement opportunity does not utilize any set-aside designations, making it open to all eligible contractors regardless of socioeconomic status or business size. The solicitation notice does not identify any incumbent contractors or provide information about current service providers for similar research activities. No award values, budget ranges, or financial parameters are specified in the available documentation, which is typical for research contracts where costs may vary significantly based on proposed methodologies and scope. The timeline for service delivery, specific quantities of research outputs, or deliverables are not outlined in the notice. The place of performance for this pilot study is not specified, though given the nature of biomedical research, it would likely be conducted at qualified research facilities or academic institutions with appropriate laboratory capabilities and regulatory compliance.